Pancreatic Cancer Research

Clinical trialObservationalUnknown

Role of Perfusion CT in Pancreatic Cancer

Evaluation of Diagnostic Efficacy of Perfusion CT Using Wide Detector for Staging and Response Prediction After Chemotherapy in Pancreatic Cancer

Outcome
Outcome unknown
Phase
Observational
Status
Unknown
Study type
Observational
Start
November 2012
Listed end
September 2021
Enrollment
48 participants
Sites
1
Primary outcomes
Evaluation of the correlation between the initial perfusion parameters of the tumor and response of the chemotherapy
Sponsor type
Academic / other
Results posted
No
Last update
8 October 2020

These fields come from the trial’s registry entry. A summary of its population, design, endpoints and results, each tied to a quote, has not been written for this trial yet.

Ask this document

Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess.

Try

Source text

Brief summary public domain (ClinicalTrials.gov)

The purpose of this study is 1. to determine whether the perfusion parameters in the normal pancreas and the pancreas cancer (adenocarcinoma or neuroendocrine tumor) are different on perfusion CT 2. to determine whether initial perfusion parameters as well as perfusion parameter change in pancreas adenocarcinoma before and after chemotherapy are different between chemotherapy response group (CR, PR according to RECIST 1.1) and non response group (SD, PD according to RECIST 1.1).

Detailed description public domain (ClinicalTrials.gov)

1. Performance of preoperative perfusion CT for preoperative staging is assessed by comparing with operative finding and histologic disease staging 2. Estimation of initial or change of pancreas cancer perfusion parameters and whether those can provide cut-off value for predicting response of chemotherapy in patients with pancreas adenocarcinoma